Medical Dermatology Therapy Update
Fibrosing Skin Disease and Vasculitis: Cases with the Masters
Release Date: June 27, 2018
Expiration Date: June 27, 2020
Estimated Time of Completion: 30 minutes
Description
Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics, as well as biologic and small-molecule therapies, as it applies to a range of important medical dermatologic conditions. In addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic diseases.
This webcast will review fibrosing skin disease and vasculitis cases.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:
Leonard H. Calabrese, DO | ||
Abbvie Pharmaceuticals, Bristol-Myers Squibb Co., Genentech/Roche, Janssen | Consulting; Teaching and Speaking | |
Crescendo | Teaching and Speaking | |
GlaxoSmithKline; Pfizer; Regeneron; Sanofi Aventis, UCB | Consulting | |
Anthony P. Fernandez, MD, PhD | ||
AbbVie Pharmaceuticals | Consulting; Independent contractor (including contracted research); Teaching and Speaking | |
Celgene Corporation | Teaching and Speaking | |
Mallinckrodt Inc. | Independent contractor (including contracted research); Teaching and Speaking | |
Roche Pharmaceuticals | Principal Investigator for a Phase III Clinical Trial | |
Neil Korman, MD, PhD | ||
Immune Pharmaceuticals Inc. | Consulting; Membership on advisory committee or review panels | |
Abbvie Pharmaceuticals | Consulting; Membership on advisory committee or review panels; Research; Teaching and Speaking | |
Janssen | Consulting; Membership on advisory committee or review panels; Teaching and Speaking | |
Novartis | Consulting; Teaching and Speaking | |
LEO | Research | |
Regeneron | Teaching and Speaking | |
Celgene Corporation, Eli Lilly, Pfizer, Inc. | Consulting; Research | |
Carol A. Langford, MD, MHS | ||
Chemocentryx | Provides research funding for clinical trial |
|
Abbvie Pharmaceuticals | Non- paid consultant for research | |
Bristol-Myers Squibb Co. | Clinical trial funding support; Non- paid consultant for research | |
Genentech, GlaxoSmithKline | Clinical trial funding support | |
The following faculty have indicated that they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:
Soumya Chatterjee, MD, MS
Christine Warren, MD
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:
Abbvie, Inc.
Genentech
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Novartis Pharmaceuticals Corporation
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:
Abbvie, Inc.
Celgene Corporation
Genentech
Genzyme Corporation
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Mallinckrodt, LLC
Novartis Pharmaceuticals Corporation
Pfizer
Valeant Pharmaceuticals North American, LLC
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the Dermatology and Plastic Surgery Institute.